Pharmafile Logo
Pharmafocus logo
Advanced Search

zactima

Showing 4 posts of 4 posts found.

AZ gets green light for thyroid cancer drug

April 7, 2011
Sales and Marketing AstraZeneca, zactima

AstraZeneca’s Zactima has become the first treatment to be approved for a rare form of thyroid cancer. The orphan drug …

News

Zactima extends progression free survival in other thyroid cancers

September 13, 2010
Research and Development thyroid cancer, zactima

New data suggests patients with the more common forms of thyroid cancer respond to AstraZeneca’s Zactima. The drug has already …

News

Zactima promising in rare thyroid cancer

June 11, 2010
Research and Development, Sales and Marketing AstraZeneca, thyroid cancer, zactima

AstraZeneca’s Zactima (vandetanib) will be filed with regulators later this year as a treatment for thyroid cancer after promising results. …

News

AstraZeneca withdraws filings for lung cancer drug

November 2, 2009
Research and Development, Sales and Marketing AZ, zactima

AstraZeneca has withdrawn marketing applications for its lung cancer drug Zactima in Europe and the US after evaluating updated results …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025